Hakon Bergheim - CEO
Hakon Bergheim joined Anaxiom Corporation in March of 2025 as the President and Chief Executive Officer.
Hakon has over 15 years of experience within medical devices in both start-up and publicly traded companies. Prior to joining Anaxiom Hakon was the Chief Operating Officer at Adagio Medical, a leading innovator in the treatment of cardiac arrhythmias.
Hakon holds a Bachelor of Science in Chemical Engineering from the University of California Irvine and Masters of Business Administration from the University of Southern California.
Sharon Riddle - VP Market and Clinical Development
Sharon brings over 30 years of expertise in KOL management and pre-clinical/clinical market development in both start-ups and large medtech companies.
Sharon was a co-founder of RadioTherapeutics and Vessix Vascular which was acquired Boston Scientific Corporation. She holds a BS in Health Science, and a Master’s in Public Health.
